Kolexia
Rouillon Clea Gastro-entérologie
Rouillon Clea
Gastro-entérologie
Hôpital Côte de Nacre
Caen, France
29 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Colite Rectocolite hémorragique Maladie de Crohn Ulcère Maladies inflammatoires intestinales Nécrose Tumeurs du sein COVID-19 Complications postopératoires

Collaborateurs

Voir plus
Viennot Stéphanie
Viennot Stéphanie
Clinique De L Alma, Paris, France
Peyrin-Biroulet Laurent
Peyrin-Biroulet Laurent
Hôpital Brabois, Vandoeuvre-lès-Nancy, France
Bouguen Guillaume
Bouguen Guillaume
Hôpital Pontchaillou, Rennes, France
Le Baut Guillaume
Le Baut Guillaume
Cabinet libéral, Champigny-sur-Marne, France

Industries

Voir plus
Abbvie
18 collaboration(s)
Dernière en 2023
Galapagos SASU
4 collaboration(s)
Dernière en 2023
Biogen
2 collaboration(s)
Dernière en 2023
Lilly
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2: A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis
Essai Clinique (Abivax S.A.)   15 décembre 2023
ABTECT - Maintenance: A Randomized, Double-blind, Multicenter Phase III Study to Evaluate the Long-term Efficacy and Safety of ABX464 25 mg or 50 mg Once Daily as a Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis
Essai Clinique (Abivax S.A.)   15 décembre 2023
EFFICACI : EFFicacy of Intravenous Infliximab Versus Vedolizumab After Failure of subCutaneous Anti-TNF in Patients With UlCerative Colitis : A Double Blinded Randomized Clinical Trial
Essai Clinique (CHU Rennes)   20 novembre 2023
The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics.
Frontiers in immunology   28 août 2023
Insights into the expanding intestinal phenotypic spectrum of SOCS1 haploinsufficiency and therapeutic options.
Journal of clinical immunology   09 mai 2023
COMET: Comparison of Azathioprine to Methotrexate in Combination Therapy With Adalimumab in Crohn's Disease: an Open-label Randomized Controlled Trial
Essai Clinique (CHU Amiens-Picardie)   07 février 2023
P404 Persistence of subcutaneous infliximab after switching from intravenous in a French national cohort of IBD patients in remission
Abstracts of the 18th Congress of ECCO Copenhagen, Denmark, March 1-4, 2023   30 janvier 2023
P443 Risk of incident Cancer in Patients with Inflammatory Bowel Disease with Prior Breast Cancer: a Multicentre Cohort Study
Abstracts of the 18th Congress of ECCO Copenhagen, Denmark, March 1-4, 2023   30 janvier 2023
DOP89 Impact of biologics on the risk of early postoperative complications in Crohn’s disease: a French nationwide study
Abstracts of the 18th Congress of ECCO Copenhagen, Denmark, March 1-4, 2023   30 janvier 2023
{{person.lastact10.name}}
{{person.lastact10.jour}}   {{person.lastact10.date}}